应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
JNJ 强生
未开盘 07-07 16:00:00 EDT
267.24
+7.91
+3.05%
盘后
267.73
+0.49
+0.18%
19:59 EDT
最高
269.43
最低
264.05
成交量
908.97万
今开
264.89
昨收
259.33
日振幅
2.08%
总市值
6,439亿
流通市值
6,426亿
总股本
24.09亿
成交额
24.31亿
换手率
0.38%
流通股本
24.05亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
异动解读｜强生盘中上涨3.14%，汇丰上调目标价至290美元
行情直击 · 07-07 22:22
异动解读｜强生盘中上涨3.14%，汇丰上调目标价至290美元
奥托马斩获3200万瑞典克朗订单
投资观察 · 07-07 16:52
奥托马斩获3200万瑞典克朗订单
汇丰：将强生(JNJ.US)目标价从280美元上调至290美元。
智通财经 · 07-06 13:22
汇丰：将强生(JNJ.US)目标价从280美元上调至290美元。
Ortoma获3200万瑞典克朗订单 强生医疗科技订购44套OTS髋关节系统
投资观察 · 07-03
Ortoma获3200万瑞典克朗订单 强生医疗科技订购44套OTS髋关节系统
异动解读｜强生盘中上涨3.02%，Tecvayli获欧洲药品管理局委员会推荐叠加机构上调目标价
行情直击 · 07-02
异动解读｜强生盘中上涨3.02%，Tecvayli获欧洲药品管理局委员会推荐叠加机构上调目标价
异动解读｜强生盘中上涨3.1%，Tecvayli联合疗法获欧洲药品管理局委员会推荐扩展适应症
行情直击 · 06-26
异动解读｜强生盘中上涨3.1%，Tecvayli联合疗法获欧洲药品管理局委员会推荐扩展适应症
美股生物医药股盘中走强，Moderna涨超11%，强生涨超3%
老虎资讯综合 · 06-26
美股生物医药股盘中走强，Moderna涨超11%，强生涨超3%
强生：已启动全球首例颈动脉血管内冲击波碎石平台关键研究的受试者招募。
智通财经 · 06-25
强生：已启动全球首例颈动脉血管内冲击波碎石平台关键研究的受试者招募。
异动解读｜强生盘中上涨3.03%，爽身粉案赔偿金获法院减半提振市场情绪
行情直击 · 06-24
异动解读｜强生盘中上涨3.03%，爽身粉案赔偿金获法院减半提振市场情绪
异动解读｜强生盘中下跌3.02%，报237.32美元
行情直击 · 06-15
异动解读｜强生盘中下跌3.02%，报237.32美元
Talvey®联合Darzalex Faspro®新数据彰显双特异性组合疗法在早期复发或难治性多发性骨髓瘤中的优势
美股速递 · 06-13
Talvey®联合Darzalex Faspro®新数据彰显双特异性组合疗法在早期复发或难治性多发性骨髓瘤中的优势
强生在美国全面推广TECNIS PureSee人工晶状体，为白内障手术提供更优选择
环球市场播报 · 06-11
强生在美国全面推广TECNIS PureSee人工晶状体，为白内障手术提供更优选择
强生(JNJ)宣布扩大其全新老花矫正人工晶体在美国市场供应范围
金吾财讯 · 06-11
强生(JNJ)宣布扩大其全新老花矫正人工晶体在美国市场供应范围
强生扩大Tecnis PureSee人工晶状体在美国市场供应，为白内障医患提供先进选择
美股速递 · 06-11
强生扩大Tecnis PureSee人工晶状体在美国市场供应，为白内障医患提供先进选择
Imaavy® (Nipocalimab-Aahu)在关键性2/3期研究中展现持久血红蛋白应答与快速起效，针对尚无FDA批准疗法的温抗体型自身免疫性溶血性贫血
美股速递 · 06-11
Imaavy® (Nipocalimab-Aahu)在关键性2/3期研究中展现持久血红蛋白应答与快速起效，针对尚无FDA批准疗法的温抗体型自身免疫性溶血性贫血
强生高管称银屑病口服药Icotyde现有约4500名处方医生 直接面向消费者营销活动预计即将启动——高盛医疗健康大会
美股速递 · 06-09
强生高管称银屑病口服药Icotyde现有约4500名处方医生 直接面向消费者营销活动预计即将启动——高盛医疗健康大会
英国MHRA授权尼泊卡单抗（商品名：Imaavy）用于治疗成人和12岁及以上青少年全身型重症肌无力
美股速递 · 06-09
英国MHRA授权尼泊卡单抗（商品名：Imaavy）用于治疗成人和12岁及以上青少年全身型重症肌无力
强生(JNJ)将以10亿美元全现金方式收购生物技术公司Firefly 卡位下一代抗体工程
金吾财讯 · 06-08
强生(JNJ)将以10亿美元全现金方式收购生物技术公司Firefly 卡位下一代抗体工程
强生拟收购Firefly Bio以拓展其肿瘤治疗产品线 引入新型降解抗体偶联平台
美股速递 · 06-08
强生拟收购Firefly Bio以拓展其肿瘤治疗产品线 引入新型降解抗体偶联平台
强生胜诉 此前有诉讼指控其滑石粉导致三名女性患癌
环球市场播报 · 06-06
强生胜诉 此前有诉讼指控其滑石粉导致三名女性患癌
加载更多
公司概况
公司名称：
强生
所属市场：
NYSE
上市日期：
--
主营业务：
强生公司于1887年在新泽西州注册成立，是医疗保健领域的全球领先企业。该公司专注于研究、开发、制造、销售种类丰富的医疗保健产品，强调人类的健康和福祉。强生通过两个主要业务部门运营：创新药物和医疗技术。
发行价格：
--
{"stockData":{"symbol":"JNJ","market":"US","secType":"STK","nameCN":"强生","latestPrice":267.24,"timestamp":1783454400000,"preClose":259.33,"halted":0,"volume":9089652,"hourTrading":{"tag":"盘后","latestPrice":267.73,"preClose":267.24,"latestTime":"19:59 EDT","volume":295609,"amount":79000629.4805,"timestamp":1783468771116,"change":0.49,"changeRate":0.001834,"amplitude":0.004228},"delay":0,"changeRate":0.030501677399452535,"floatShares":2404573193,"shares":2409295102,"eps":8.635366,"marketStatus":"未开盘","change":7.91,"latestTime":"07-07 16:00:00 EDT","open":264.89,"high":269.43,"low":264.045,"amount":2430868358.49,"amplitude":0.020765,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":8.635366,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1783497600000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":-797371200000,"exchange":"NYSE","adjPreClose":259.33,"dividendRate":0.019458,"preHourTrading":{"tag":"盘前","latestPrice":264.49,"preClose":259.33,"latestTime":"09:29 EDT","volume":8543,"amount":2243046.40651,"timestamp":1783430999301,"change":5.16,"changeRate":0.019897,"amplitude":0.019897},"postHourTrading":{"tag":"盘后","latestPrice":267.73,"preClose":267.24,"latestTime":"19:59 EDT","volume":295609,"amount":79000629.4805,"timestamp":1783468771116,"change":0.49,"changeRate":0.001834,"amplitude":0.004228},"volumeRatio":1.183584,"optionData":{"bulkOrders":[{"symbol":"JNJ","call":false,"expireDate":1784260800000,"strike":"242.5","timestamp":1783433724963,"price":0.66,"volume":4070,"amount":268620,"type":"-"},{"symbol":"JNJ","call":false,"expireDate":1784260800000,"strike":"242.5","timestamp":1783433724963,"price":0.65,"volume":3522,"amount":228930,"type":"-"}]},"impliedVol":0.3175,"impliedVolPercentile":0.996},"requestUrl":"/m/hq/s/JNJ","defaultTab":"news","newsList":[{"id":"1137355286","title":"异动解读｜强生盘中上涨3.14%，汇丰上调目标价至290美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1137355286","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137355286?lang=zh_cn&edition=full","pubTime":"2026-07-07 22:22","pubTimestamp":1783434169,"startTime":"0","endTime":"0","summary":"7月7日，强生盘中上涨3.14%，报267.74美元/股，成交额4.76亿美元。消息面上，汇丰银行于7月6日将强生目标价从280美元上调至290美元。此前古根海姆也将目标价从266美元上调至270美元并维持买入评级。据FactSet统计，强生当前平均评级为增持，一致目标价262.57美元。公司下次财报将于7月15日盘前公布，市场预期EPS为2.83美元。强生公司是医疗保健领域的全球领先企业，通过创新药物和医疗技术两大业务部门运营。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JNJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145675744","title":"奥托马斩获3200万瑞典克朗订单","url":"https://stock-news.laohu8.com/highlight/detail?id=1145675744","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145675744?lang=zh_cn&edition=full","pubTime":"2026-07-07 16:52","pubTimestamp":1783414335,"startTime":"0","endTime":"0","summary":"奥托马公司近日宣布，其获得了强生医疗科技公司一份价值3200万瑞典克朗的订单。根据订单内容，强生医疗科技将采购44套奥托马髋关节系统，这些产品将销往欧洲、美国及日本市场。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","LU2750360997.AUD","LU2213496289.HKD","LU1244550494.USD","LU2023250330.USD","LU0889566641.SGD","IE0001KFT4U8.USD","LU1585245621.USD","IE00B4R5TH58.HKD","SG9999002232.USD","LU0820561818.USD","IE0002141913.USD","IE00BSNM7G36.USD","LU0114720955.EUR","IE00B19Z3581.USD","LU0234572021.USD","IE00BFTCPJ56.SGD","LU1280957306.USD","LU2456880835.USD","BK4550","LU2602419157.SGD","LU2896262040.SGD","LU0345770993.USD","LU1914381329.SGD","IE00BDGV0183.EUR","IE00BZ1G4Q59.USD","LU1057294990.SGD","IE00B3T34201.USD","LU0683600562.USD","LU1066051811.HKD","LU2089984988.USD","SGXZ57979304.SGD","LU0053666078.USD","SG9999002224.SGD","LU1983299246.USD","RXL","LU1074936037.SGD","LU2471134796.USD","PJP","IE00B2B36J28.USD","BK4559","IE00BLSP4452.SGD","IE000BZT7R73.USD","LU1043141123.HKD","IE0000B7K699.USD","LU2505996681.GBP","LU0289739699.SGD","FHLC","LU0426417589.USD","LU2468319806.SGD","LU2505996509.AUD","IE00B42XCP33.USD","LU0820562030.AUD","LU1551013425.SGD","LU2236285917.USD","BK4534","IE00BFXG1179.USD","LU0795875086.SGD","LU2756315664.SGD","LU0203347892.USD","IE000M9KFDE8.USD","LU1066051225.USD","LU2129689514.USD","LU2471134879.HKD","BK4532","LU0466842654.USD","IE00B7SZLL34.SGD","LU0070217475.USD","LU0432979614.USD","LU1718418525.SGD","SG9999001176.SGD","LU1929549753.HKD","LU1894683264.USD","LU0124676726.USD","BK4568","LU1496350502.SGD","LU1221951046.USD","LU2129689605.HKD","LU0545562505.USD","LU1121112475.USD","LU2430703178.SGD","LU0985320562.USD","LU0882574055.USD","BK4592","IE0034235303.USD","SG9999001440.SGD","LU2112291526.USD","VHT","LU0122379950.USD","LU0689472784.USD","LU2487616109.SGD","IYH","LU2133065610.SGD","IE00BVYPNV92.GBP","BMED","LU0203345920.USD","LU1244550221.USD","IE000SO60NU8.SGD","LU0943347566.SGD","LU1066051498.USD","LU1506573853.SGD","IE00BJJMRZ35.SGD","LU2756315318.SGD","FTXH","LU2403377893.USD","IE00BBT3K403.USD","XLV","LU1023059063.AUD","LU0234570918.USD","LU1032955483.USD","BK4585","LU1145028129.USD","LU1162221912.USD","IE000MB6IJN5.SGD","LU0795875169.SGD","LU1061106388.HKD","IE0002270589.USD","LU0058720904.USD","LU0210536198.USD","LU1674673691.USD","LU2129689431.USD","JDOC","LU0912757837.SGD","IE00BLSP4239.USD","LU1674673428.USD","GDOC","LU2592432038.USD","LU1629891620.HKD","IXJ","LU2347655156.SGD","LU0964807845.USD","IE00B1BXHZ80.USD","IE00BVYPNW00.USD","LU0640476718.USD","LU0426412945.USD","IHE","LU1430594728.SGD","LU1894683348.USD","LU1221951129.SGD","BK4581","LU1196500208.SGD","LU1244550577.SGD","SG9999013999.USD","LU2430703095.HKD","LU0787776722.HKD","LU2750360641.GBP","LU1228905540.USD","IE000WAW04H5.SGD","LU1261432733.SGD","LU2471134952.CNY","IE00BKVL7J92.USD","LU1778281490.HKD","BK4504","LU0098860793.USD","JNJ","IE0009355771.USD","LU0792757196.USD","LU0345770308.USD","LU1043141396.HKD","LU0820561909.HKD","LU1732800096.USD","LU0345769128.USD","LU0320765646.SGD","LU0689626769.HKD","LU1059921491.USD","SG9999001176.USD","LU0345769631.USD","LU0210528500.USD","LU2417539215.USD","IE00BN8TJ469.HKD","LU1732799900.SGD","LU0994945656.USD","IE000F7OJYX1.SGD","LU1267930813.SGD","LU1551013342.USD","LU1066053197.SGD","BK4588","LU2471134523.USD","IE00B19Z3B42.SGD","LU1032466523.USD","LU1935042991.SGD","IE00BGHQF631.EUR","LU2430703251.USD","LU1228905037.USD","BK4007","IE00BJT1NW94.SGD","MEDX","IE00B3PB1722.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649643484","title":"汇丰：将强生(JNJ.US)目标价从280美元上调至290美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2649643484","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649643484?lang=zh_cn&edition=full","pubTime":"2026-07-06 13:22","pubTimestamp":1783315337,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2756315664.SGD","LU0053666078.USD","LU2602419157.SGD","IE000M9KFDE8.USD","LU0689472784.USD","IYH","IE00B1BXHZ80.USD","JDOC","LU0052756011.USD","LU0098860793.USD","JNJ","LU2471134796.USD","MEDX","GDOC","LU2592432038.USD","PJP","LU0211326839.USD","LU2487616109.SGD","LU1267930813.SGD","RXL","VHT","UDN","LU0310800965.SGD","LU1894683264.USD","LU1629891620.HKD","BK4532","IE00BZ1G4Q59.USD","LU0882574055.USD","BMED","LU1506573853.SGD","SG9999001176.SGD","LU1674673428.USD","IE00B4R5TH58.HKD","HSBH","FHLC","IE00BVYPNV92.GBP","IE00BDGV0183.EUR","LU0976567544.SGD","UUP","IE00BVYPNW00.USD","IHE","LU1061106388.HKD","IE0009355771.USD","LU2468319806.SGD","LU0234572021.USD","XLV","FTXH","IXJ","HSBC","LU2129689431.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197788462","title":"Ortoma获3200万瑞典克朗订单 强生医疗科技订购44套OTS髋关节系统","url":"https://stock-news.laohu8.com/highlight/detail?id=1197788462","media":"投资观察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197788462?lang=zh_cn&edition=full","pubTime":"2026-07-03 17:33","pubTimestamp":1783071229,"startTime":"0","endTime":"0","summary":"Ortoma AB近日宣布，已获得一笔价值3200万瑞典克朗的订单。这笔订单来自强生旗下的医疗科技部门，内容为订购44套OTS髋关节系统，将供应至欧洲、美国及日本市场。\n该订单的签订，标志着Ortoma的核心产品在关键国际市场获得了重要客户的认可。OTS髋关节系统是Ortoma的旗舰产品之一，此次大规模采购将有助于提升其在全球骨科手术机器人领域的市场份额与影响力。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3PB1722.GBP","LU1718418525.SGD","IE00BLSP4239.USD","LU0795875086.SGD","LU1430594728.SGD","LU1066051225.USD","LU1280957306.USD","SG9999001440.SGD","LU2347655156.SGD","LU0820561818.USD","IE00B1BXHZ80.USD","LU1043141396.HKD","LU0234570918.USD","LU0943347566.SGD","LU1059921491.USD","BK4568","IE0002270589.USD","LU0432979614.USD","LU1221951129.SGD","IE00B42XCP33.USD","LU0053666078.USD","LU2471134952.CNY","LU1244550494.USD","LU0345769631.USD","LU1674673428.USD","LU1032466523.USD","LU1506573853.SGD","IE00BVYPNW00.USD","LU2505996681.GBP","IE00BZ1G4Q59.USD","LU1244550221.USD","LU0320765646.SGD","IE00BKVL7J92.USD","LU2133065610.SGD","LU0683600562.USD","LU0689472784.USD","LU1629891620.HKD","LU0820561909.HKD","IE00B2B36J28.USD","IE000BZT7R73.USD","IE00B3T34201.USD","JNJ","BK4559","SG9999001176.USD","LU2089984988.USD","LU2471134523.USD","IE00BLSP4452.SGD","LU2468319806.SGD","LU1228905037.USD","BK4588","LU0466842654.USD","LU1228905540.USD","LU2592432038.USD","LU2129689514.USD","LU1914381329.SGD","IE000M9KFDE8.USD","LU1894683264.USD","LU1551013425.SGD","IE0000B7K699.USD","LU0912757837.SGD","LU2430703095.HKD","LU1066053197.SGD","LU0210536198.USD","LU2417539215.USD","LU1066051811.HKD","IE00BN8TJ469.HKD","LU1244550577.SGD","LU1496350502.SGD","LU0820562030.AUD","LU0345769128.USD","BK4581","LU2456880835.USD","LU0203347892.USD","IE00BJT1NW94.SGD","LU1032955483.USD","IE0009355771.USD","LU1983299246.USD","LU1145028129.USD","LU2430703178.SGD","LU0345770993.USD","LU0787776722.HKD","LU1732800096.USD","LU2896262040.SGD","SG9999002232.USD","LU1732799900.SGD","LU1074936037.SGD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","LU1929549753.HKD","LU2602419157.SGD","BK4550","LU1267930813.SGD","LU1674673691.USD","LU0426417589.USD","LU0070217475.USD","LU1935042991.SGD","LU0640476718.USD","IE000WAW04H5.SGD","LU1023059063.AUD","BK4007","LU0985320562.USD","LU1894683348.USD","IE00BFXG1179.USD","LU2487616109.SGD","LU2750360997.AUD","SG9999001176.SGD","LU2750360641.GBP","LU2756315664.SGD","BK4532","LU0345770308.USD","LU2471134879.HKD","LU1061106388.HKD","LU2403377893.USD","LU2430703251.USD","IE00BBT3K403.USD","LU2213496289.HKD","IE00BDGV0183.EUR","LU0058720904.USD","LU0124676726.USD","LU2756315318.SGD","LU1261432733.SGD","IE0002141913.USD","BK4592","LU0426412945.USD","LU2505996509.AUD","IE00BSNM7G36.USD","IE00BFTCPJ56.SGD","BK4533","LU1043141123.HKD","LU0994945656.USD","LU2471134796.USD","LU2112291526.USD","SG9999002224.SGD","LU2129689431.USD","IE000SO60NU8.SGD","LU1196500208.SGD","LU0203345920.USD","LU0882574055.USD","IE000MB6IJN5.SGD","LU1057294990.SGD","LU2236285917.USD","LU0210528500.USD","LU1066051498.USD","LU2023250330.USD","BK4534","LU0964807845.USD","LU0114720955.EUR","LU0098860793.USD","IE00BVYPNV92.GBP","LU1221951046.USD","IE00B19Z3B42.SGD","SG9999013999.USD","SGXZ57979304.SGD","LU0689626769.HKD","LU1551013342.USD","BK4504","LU1121112475.USD","IE00BGHQF631.EUR","LU0122379950.USD","LU1778281490.HKD","LU0289739699.SGD","BK4585","IE00B19Z3581.USD","IE000F7OJYX1.SGD","LU0234572021.USD","LU1585245621.USD","IE00B7SZLL34.SGD","LU0795875169.SGD","LU0889566641.SGD","LU0545562505.USD","LU2129689605.HKD","LU1162221912.USD","IE0001KFT4U8.USD","LU0792757196.USD","IE0034235303.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127706542","title":"异动解读｜强生盘中上涨3.02%，Tecvayli获欧洲药品管理局委员会推荐叠加机构上调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1127706542","media":"行情直击","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127706542?lang=zh_cn&edition=full","pubTime":"2026-07-02 23:08","pubTimestamp":1783004901,"startTime":"0","endTime":"0","summary":"7月2日，强生盘中上涨3.02%，报261.49美元/股，成交额3.78亿美元。消息面上，近日欧洲药品管理局人用医药产品委员会建议扩大Tecvayli联合达雷妥尤单抗在复发或难治性多发性骨髓瘤成人患者中的适应症。与此同时，古根海姆将强生目标价从266美元上调至270美元并维持买入评级。强生公司于1887年在新泽西州注册成立，是医疗保健领域的全球领先企业，通过创新药物和医疗技术两大业务部门运营。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JNJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173784442","title":"异动解读｜强生盘中上涨3.1%，Tecvayli联合疗法获欧洲药品管理局委员会推荐扩展适应症","url":"https://stock-news.laohu8.com/highlight/detail?id=1173784442","media":"行情直击","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173784442?lang=zh_cn&edition=full","pubTime":"2026-06-26 22:29","pubTimestamp":1782484141,"startTime":"0","endTime":"0","summary":"6月26日，强生盘中上涨3.1%，报253.11美元/股，成交额6.95亿美元。该推荐基于III期MajesTEC-3研究数据，结果显示接受teclistamab联合达雷妥尤单抗皮下注射的患者，疾病进展或死亡风险较标准治疗降低83.4%。同日，古根海姆将强生目标价由266美元上调至270美元，维持买入评级。强生所在的制药行业中，礼来涨5.88%、默沙东涨2.44%、辉瑞涨2.4%、诺和诺德涨1.34%、诺华涨0.54%，板块整体表现偏暖。强生公司是医疗保健领域的全球领先企业，通过创新药物和医疗技术两大业务部门运营。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JNJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116783699","title":"美股生物医药股盘中走强，Moderna涨超11%，强生涨超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1116783699","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116783699?lang=zh_cn&edition=full","pubTime":"2026-06-26 22:14","pubTimestamp":1782483252,"startTime":"0","endTime":"0","summary":"6月26日，美股生物医药股盘中走强，$Moderna(MRNA)$涨超11%，$强生(JNJ)$涨超3%，$辉瑞(PFE)$、$施贵宝(BMY)$、$默沙东(MRK)$、$诺瓦瓦克斯医药(NVAX)$涨超2%。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002141913.USD","LU0787776722.HKD","LU1023059063.AUD","LU2471134879.HKD","IE0034235303.USD","LU1430594728.SGD","LU2417539215.USD","LU2505996681.GBP","IE00BSNM7G36.USD","LU1196500208.SGD","LU0640476718.USD","LU1244550577.SGD","LU1551013342.USD","LU1551013425.SGD","LU1674673428.USD","LU1244550221.USD","IE00BKVL7J92.USD","LU2129689605.HKD","LU0234572021.USD","LU0889566641.SGD","BK4592","LU0426417589.USD","BK4504","LU2592432038.USD","LU1732800096.USD","SGXZ57979304.SGD","LU2505996509.AUD","IE000WAW04H5.SGD","LU1674673691.USD","LU1066051811.HKD","LU0820561909.HKD","LU2089984988.USD","LU1032955483.USD","LU0985320562.USD","SG9999013999.USD","LU0689626769.HKD","BK4568","LU0545562505.USD","LU1221951129.SGD","IE000SO60NU8.SGD","BK4007","LU0795875086.SGD","IE00B3T34201.USD","LU1032466523.USD","LU1267930813.SGD","LU2133065610.SGD","LU0689472784.USD","IE00B3PB1722.GBP","BK4534","LU1280957306.USD","LU1935042991.SGD","IE00B42XCP33.USD","LU2213496289.HKD","LU1778281490.HKD","BK4550","LU1066051498.USD","LU0432979614.USD","IE00B7SZLL34.SGD","LU0098860793.USD","LU2468319806.SGD","LU0124676726.USD","LU1162221912.USD","LU0964807845.USD","161726","LU1066053197.SGD","LU0345770308.USD","LU0795875169.SGD","LU1718418525.SGD","IE00BJT1NW94.SGD","LU0426412945.USD","LU1261432733.SGD","LU1732799900.SGD","LU2129689431.USD","XBI","LU2403377893.USD","LU0053666078.USD","SG9999001176.SGD","LU0345770993.USD","LU0820562030.AUD","IE0009355771.USD","LU0203347892.USD","LU0114720955.EUR","LU1585245621.USD","LU2487616109.SGD","LU2750360997.AUD","IE00BVYPNV92.GBP","LU1221951046.USD","LU2471134952.CNY","LU2023250330.USD","LU0210536198.USD","LU1629891620.HKD","LU1145028129.USD","IE00BBT3K403.USD","LU2756315664.SGD","LU0070217475.USD","LU1929549753.HKD","LU1228905540.USD","LU0203345920.USD","LU0820561818.USD","IE000BZT7R73.USD","LU1043141396.HKD","IE00BN8TJ469.HKD","LU1059921491.USD","IE0002270589.USD","IE00B2B36J28.USD","LU2236285917.USD","LU1121112475.USD","LU2430703178.SGD","LU2456880835.USD","SG9999001176.USD","SG9999002224.SGD","LU1066051225.USD","LU2471134523.USD","IE00B19Z3B42.SGD","LU0122379950.USD","LU0994945656.USD","LU2471134796.USD","LU2756315318.SGD","BK4585","BK4588","LU1043141123.HKD","BK4559","IE00BFXG1179.USD","LU0289739699.SGD","LU1506573853.SGD","LU2430703251.USD","LU0683600562.USD","LU2430703095.HKD","IE00BVYPNW00.USD","LU2112291526.USD","LU0234570918.USD","LU1074936037.SGD","SG9999001440.SGD","JNJ","LU0882574055.USD","IE00BLSP4452.SGD","IE00BLSP4239.USD","BK4581","IE00BGHQF631.EUR","LU0943347566.SGD","SG9999002232.USD","LU2896262040.SGD","LU0058720904.USD","LU0912757837.SGD","LU1057294990.SGD","LU1894683264.USD","LU0792757196.USD","LU1914381329.SGD","399441","LU2129689514.USD","LU0320765646.SGD","LU2602419157.SGD","IE00BJJMRZ35.SGD","IE00BDGV0183.EUR","IE00BFTCPJ56.SGD","LU2750360641.GBP","IE0000B7K699.USD","LU0466842654.USD","LU1983299246.USD","IE00B1BXHZ80.USD","LU1061106388.HKD","LU1496350502.SGD","IE0001KFT4U8.USD","IE00B19Z3581.USD","LU1244550494.USD","BK4532","LU2347655156.SGD","IE000MB6IJN5.SGD","IE00B4R5TH58.HKD","LU0345769631.USD","LU0345769128.USD","BK4533","IE000M9KFDE8.USD","LU1228905037.USD","IE00BZ1G4Q59.USD","LU0210528500.USD","IE000F7OJYX1.SGD","LU1894683348.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646771748","title":"强生：已启动全球首例颈动脉血管内冲击波碎石平台关键研究的受试者招募。","url":"https://stock-news.laohu8.com/highlight/detail?id=2646771748","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646771748?lang=zh_cn&edition=full","pubTime":"2026-06-25 19:47","pubTimestamp":1782388054,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0795875086.SGD","LU0053666078.USD","LU1162221912.USD","SG9999001440.SGD","LU0345769128.USD","LU2133065610.SGD","LU1935042991.SGD","LU1732800096.USD","LU0426412945.USD","LU0203345920.USD","JNJ","BK4504","LU1244550494.USD","LU1261432733.SGD","LU1585245621.USD","LU0943347566.SGD","LU1914381329.SGD","LU2236285917.USD","IE00BGHQF631.EUR","LU0912757837.SGD","LU1674673691.USD","LU2592432038.USD","BK4588","BK4534","LU1718418525.SGD","LU1894683264.USD","LU0432979614.USD","IE00B3T34201.USD","LU0964807845.USD","IE0002270589.USD","LU0683600562.USD","LU2129689605.HKD","LU1145028129.USD","LU0545562505.USD","LU1221951129.SGD","LU2089984988.USD","IE00B4R5TH58.HKD","IE00BVYPNV92.GBP","LU2112291526.USD","IE00B19Z3581.USD","SG9999002224.SGD","IE00BVYPNW00.USD","LU1551013342.USD","LU1023059063.AUD","LU2430703178.SGD","LU1059921491.USD","LU2213496289.HKD","LU2430703095.HKD","IE000F7OJYX1.SGD","IE0001KFT4U8.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109899052","title":"异动解读｜强生盘中上涨3.03%，爽身粉案赔偿金获法院减半提振市场情绪","url":"https://stock-news.laohu8.com/highlight/detail?id=1109899052","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109899052?lang=zh_cn&edition=full","pubTime":"2026-06-24 02:55","pubTimestamp":1782240910,"startTime":"0","endTime":"0","summary":"6月24日，强生盘中上涨3.03%，报238.3美元/股，成交额12.34亿美元。消息面上，法院对强生爽身粉诉讼案作出最新裁定，将此前判赔金额减半至21亿美元，强生方面表示将继续上诉。赔偿金额大幅缩减缓解了市场对公司诉讼风险敞口的担忧，短期内对股价形成正面支撑。强生所在的制药行业中，默沙东涨3.15%、诺和诺德涨2.02%、礼来涨0.6%，板块整体表现偏暖，对强生股价亦形成协同助推。强生公司是医疗保健领域的全球领先企业，通过创新药物和医疗技术两大业务部门运营。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JNJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162854079","title":"异动解读｜强生盘中下跌3.02%，报237.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1162854079","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162854079?lang=zh_cn&edition=full","pubTime":"2026-06-15 22:59","pubTimestamp":1781535577,"startTime":"0","endTime":"0","summary":"6月15日，强生盘中下跌3.02%，报237.32美元/股，成交额3.85亿美元。强生所在的制药行业中，个股表现分化，其中礼来涨0.09%，默沙东跌1.7%，辉瑞涨0.55%，诺和诺德涨1.31%，施贵宝跌1.23%。强生跌幅明显大于同业，表现显著弱于板块整体水平。强生公司于1887年在新泽西州注册成立，是医疗保健领域的全球领先企业，通过创新药物和医疗技术两个主要业务部门运营，专注于研究、开发、制造、销售种类丰富的医疗保健产品。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JNJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176248398","title":"Talvey®联合Darzalex Faspro®新数据彰显双特异性组合疗法在早期复发或难治性多发性骨髓瘤中的优势","url":"https://stock-news.laohu8.com/highlight/detail?id=1176248398","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176248398?lang=zh_cn&edition=full","pubTime":"2026-06-13 18:35","pubTimestamp":1781346915,"startTime":"0","endTime":"0","summary":"最新公布的Talvey®（Talquetamab-Tgvs）联合Darzalex Faspro®（达雷妥尤单抗与透明质酸酶-fihj）研究数据，有力证实了这种双特异性抗体组合方案在治疗早期复发或难治性多发性骨髓瘤患者中的显著疗效与临床价值。该结果凸显了这一创新联合疗法在提升治疗深度与持久性方面的潜力，为多发性骨髓瘤的治疗格局带来了新的希望。研究数据显示，联合疗法在关键疗效指标上表现出积极且稳健的结果，进一步支持了其在临床实践中的应用前景。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0689472784.USD","LU0689626769.HKD","LU0820561909.HKD","IE000SO60NU8.SGD","LU1674673691.USD","LU0070217475.USD","SG9999002232.USD","LU0345769128.USD","LU0545562505.USD","LU2023250330.USD","LU2456880835.USD","LU2505996681.GBP","LU2133065610.SGD","BK4504","LU2471134879.HKD","LU2129689514.USD","LU1935042991.SGD","IE00BDGV0183.EUR","BK4585","BK4007","LU0820562030.AUD","LU2592432038.USD","LU1043141123.HKD","LU1983299246.USD","IE00BVYPNW00.USD","IE00BVYPNV92.GBP","LU2756315318.SGD","BK4568","LU0787776722.HKD","LU1718418525.SGD","BK4581","IE00B1BXHZ80.USD","LU2471134952.CNY","LU0795875169.SGD","LU0210536198.USD","LU2471134523.USD","LU0122379950.USD","IE000MB6IJN5.SGD","IE00B19Z3581.USD","LU0289739699.SGD","LU0795875086.SGD","SG9999013999.USD","IE00BSNM7G36.USD","LU1551013342.USD","SG9999001440.SGD","IE00BN8TJ469.HKD","JNJ","LU1894683264.USD","LU0345770308.USD","LU1244550221.USD","LU0466842654.USD","BK4534","IE0002141913.USD","LU0994945656.USD","LU1914381329.SGD","SG9999002224.SGD","IE00B7SZLL34.SGD","IE00B4R5TH58.HKD","LU2756315664.SGD","LU0964807845.USD","BK4588","LU0426417589.USD","LU1629891620.HKD","LU1430594728.SGD","LU0234570918.USD","IE000M9KFDE8.USD","BK4532","IE000BZT7R73.USD","LU2129689431.USD","LU2602419157.SGD","LU0683600562.USD","LU0234572021.USD","LU1043141396.HKD","IE000WAW04H5.SGD","LU1162221912.USD","LU1032466523.USD","LU0345770993.USD","LU1732800096.USD","LU2213496289.HKD","LU1551013425.SGD","LU2430703251.USD","IE00BFTCPJ56.SGD","LU2430703178.SGD","LU0203347892.USD","SGXZ57979304.SGD","LU0432979614.USD","LU1066051498.USD","IE0001KFT4U8.USD","LU1059921491.USD","IE00BBT3K403.USD","LU2089984988.USD","LU0943347566.SGD","LU1032955483.USD","LU1894683348.USD","LU2750360641.GBP","BK4559","IE0034235303.USD","LU1023059063.AUD","LU1066053197.SGD","IE00BJT1NW94.SGD","LU1244550494.USD","LU2347655156.SGD","IE0000B7K699.USD","LU1496350502.SGD","IE00BKVL7J92.USD","LU1074936037.SGD","IE00B42XCP33.USD","IE00BZ1G4Q59.USD","LU1145028129.USD","LU1221951046.USD","LU0098860793.USD","IE00B19Z3B42.SGD","LU0820561818.USD","LU1732799900.SGD","LU1057294990.SGD","LU0114720955.EUR","LU1778281490.HKD","LU2112291526.USD","IE00B2B36J28.USD","IE00BGHQF631.EUR","LU0792757196.USD","LU2750360997.AUD","LU1244550577.SGD","LU2505996509.AUD","IE00BLSP4452.SGD","LU1506573853.SGD","LU1267930813.SGD","LU0345769631.USD","LU2487616109.SGD","LU2129689605.HKD","LU1196500208.SGD","LU1121112475.USD","BK4533","LU0640476718.USD","SG9999001176.USD","IE00BJJMRZ35.SGD","LU1066051225.USD","LU2471134796.USD","IE0002270589.USD","LU0053666078.USD","IE0009355771.USD","LU1674673428.USD","LU0426412945.USD","LU1261432733.SGD","LU2236285917.USD","LU1929549753.HKD","LU0210528500.USD","LU1228905540.USD","LU2896262040.SGD","LU1221951129.SGD","IE000F7OJYX1.SGD","SG9999001176.SGD","LU2403377893.USD","IE00BFXG1179.USD","LU2430703095.HKD","BK4550","IE00BLSP4239.USD","LU1228905037.USD","LU2417539215.USD","LU0882574055.USD","LU1585245621.USD","IE00B3PB1722.GBP","LU1066051811.HKD","LU1280957306.USD","IE00B3T34201.USD","LU2468319806.SGD","LU1061106388.HKD","BK4592","LU0058720904.USD","LU0124676726.USD","LU0889566641.SGD","LU0985320562.USD","LU0912757837.SGD","LU0320765646.SGD","LU0203345920.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642528047","title":"强生在美国全面推广TECNIS PureSee人工晶状体，为白内障手术提供更优选择","url":"https://stock-news.laohu8.com/highlight/detail?id=2642528047","media":"环球市场播报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642528047?lang=zh_cn&edition=full","pubTime":"2026-06-11 22:15","pubTimestamp":1781187300,"startTime":"0","endTime":"0","summary":"强生公司本周宣布，其研发的TECNIS PureSee人工晶状体正式在美国全面上市。 TECNIS PureSee人工晶状体是首款获得美国食品药品监督管理局批准的扩展焦深人工晶状体，且无需在标签上标注对比敏感度下降的警告。 强生公司外科视觉北美区总裁表示，随着TECNIS PureSee人工晶状体在美国全面上市，他们正在为更多患者提供这一重要的扩展焦深视力解决方案，患者希望获得能够支持其日常生活的视力方案。目前，全球已有超过50万只眼睛植入了TECNIS PureSee人工晶状体。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-06-11/doc-inicaene5368536.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["SG9999002232.USD","LU2505996509.AUD","LU1074936037.SGD","IE00BLSP4239.USD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","JNJ","SG9999001176.USD","LU1066051225.USD","LU2089984988.USD","LU1280957306.USD","LU2471134523.USD","LU1674673691.USD","LU2112291526.USD","LU2129689431.USD","LU1196500208.SGD","LU0882574055.USD","LU0070217475.USD","LU1935042991.SGD","LU0234570918.USD","IE000WAW04H5.SGD","LU0640476718.USD","LU1059921491.USD","LU1228905540.USD","LU2129689514.USD","LU1894683348.USD","LU0210528500.USD","LU1674673428.USD","SG9999001176.SGD","LU2756315664.SGD","LU0210536198.USD","LU1066051811.HKD","SGXZ57979304.SGD","LU1496350502.SGD","IE00BZ1G4Q59.USD","LU1244550221.USD","LU1061106388.HKD","LU2430703251.USD","LU2213496289.HKD","BK4585","LU2129689605.HKD","IE00BKVL7J92.USD","LU0058720904.USD","LU1983299246.USD","LU2756315318.SGD","IE0001KFT4U8.USD","IE0002141913.USD","LU0792757196.USD","LU1145028129.USD","LU1629891620.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642820842","title":"强生(JNJ)宣布扩大其全新老花矫正人工晶体在美国市场供应范围","url":"https://stock-news.laohu8.com/highlight/detail?id=2642820842","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642820842?lang=zh_cn&edition=full","pubTime":"2026-06-11 21:08","pubTimestamp":1781183310,"startTime":"0","endTime":"0","summary":"金吾财讯 | 强生公司(JNJ)旗下眼科手术业务部宣布，将正式扩大其最新一代老花眼矫正人工晶状体(PC-IOL)——TECNIS PureSee在全美市场的商业化供应范围。目前，该产品在全球已累计完成超过50万例临床植入，患者满意度及推荐率高达97%。据悉，该晶体是全美首款、也是唯一一款获得美国食品药品监督管理局(FDA)批准、且未被附加“对比敏感度降低”警告的连续景深(EDOF)人工晶状体。强生该新晶体实现了与单焦点晶体相媲美的视觉清晰度。临床数据显示，该晶体能为白内障及老花眼患者提供卓越的远距离、中距离视力以及部分近距离视力。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250107/OTc4NDY1YzgwYTY5ZDI5OGQwMTAxMzU2NDM1Mjg5Ng==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/OTc4NDY1YzgwYTY5ZDI5OGQwMTAxMzU2NDM1Mjg5Ng==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"301452","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0426412945.USD","LU2505996681.GBP","LU1585245621.USD","JNJ","LU2236285917.USD","LU2750360997.AUD","IE000SO60NU8.SGD","IE00B4R5TH58.HKD","LU1023059063.AUD","LU0466842654.USD","LU1261432733.SGD","LU1121112475.USD","LU1674673691.USD","IE0000B7K699.USD","LU2089984988.USD","LU2112291526.USD","LU1430594728.SGD","LU2023250330.USD","SG9999013999.USD","IE00BFXG1179.USD","LU0124676726.USD","LU0320765646.SGD","IE00B19Z3581.USD","LU0426417589.USD","LU0985320562.USD","LU2430703095.HKD","IE00B7SZLL34.SGD","SG9999002224.SGD","IE00B2B36J28.USD","IE0002270589.USD","LU0912757837.SGD","LU1551013425.SGD","IE00B3T34201.USD","LU0545562505.USD","LU2602419157.SGD","LU1066051498.USD","IE00BVYPNW00.USD","LU0345770308.USD","BK4533","LU2505996509.AUD","LU0792757196.USD","LU1674673428.USD","LU0234570918.USD","BK4581","LU0820561909.HKD","LU0943347566.SGD","LU1228905540.USD","LU0234572021.USD","SG9999001176.USD","LU2471134523.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188867942","title":"强生扩大Tecnis PureSee人工晶状体在美国市场供应，为白内障医患提供先进选择","url":"https://stock-news.laohu8.com/highlight/detail?id=1188867942","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188867942?lang=zh_cn&edition=full","pubTime":"2026-06-11 19:46","pubTimestamp":1781178384,"startTime":"0","endTime":"0","summary":"强生公司宣布，将扩大其先进人工晶状体产品Tecnis PureSee在美国市场的可及性。此举旨在为白内障手术医生及患者提供一项创新的视力矫正解决方案。\nTecnis PureSee是一款专为白内障患者设计的高端人工晶状体。其技术特点在于能够为患者提供更广泛的视程范围，并有望减少术后对眼镜的依赖。该产品的推广，反映了强生在眼科医疗设备领域持续创新的战略布局。\n通过提升该产品在美国的供应能力，强生期望满足日益增长的市场需求，并为白内障手术患者带来更优质的视觉结果和生活质量改善。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1043141396.HKD","LU0943347566.SGD","LU1066051225.USD","IE00BZ1G4Q59.USD","LU2471134796.USD","LU0114720955.EUR","LU2750360641.GBP","LU1228905037.USD","LU0787776722.HKD","LU0820562030.AUD","LU2430703095.HKD","LU0882574055.USD","LU2471134523.USD","IE00BKVL7J92.USD","LU1074936037.SGD","LU1221951129.SGD","LU1718418525.SGD","LU0792757196.USD","LU2471134952.CNY","BK4581","IE000F7OJYX1.SGD","LU0889566641.SGD","LU0912757837.SGD","LU0466842654.USD","LU1244550494.USD","LU1032955483.USD","LU1914381329.SGD","LU0345769631.USD","LU0210536198.USD","IE0002141913.USD","IE00BLSP4239.USD","IE00B2B36J28.USD","BK4550","LU0345770993.USD","IE00BDGV0183.EUR","IE00BJJMRZ35.SGD","LU1629891620.HKD","LU1935042991.SGD","LU0964807845.USD","LU1430594728.SGD","SG9999001176.SGD","LU0058720904.USD","LU0795875086.SGD","LU2750360997.AUD","LU1043141123.HKD","LU0210528500.USD","IE00BSNM7G36.USD","LU0203347892.USD","LU1983299246.USD","IE00B42XCP33.USD","LU0545562505.USD","LU2213496289.HKD","LU1145028129.USD","LU2756315664.SGD","LU2417539215.USD","LU1267930813.SGD","IE0001KFT4U8.USD","LU1585245621.USD","BK4504","LU0683600562.USD","LU1674673428.USD","BK4568","LU1732800096.USD","LU1929549753.HKD","LU0203345920.USD","LU2505996509.AUD","IE00BFTCPJ56.SGD","LU2592432038.USD","IE00B19Z3581.USD","LU1244550221.USD","LU1551013425.SGD","LU0070217475.USD","LU2468319806.SGD","BK4559","BK4533","LU2602419157.SGD","LU0795875169.SGD","LU1023059063.AUD","IE0002270589.USD","IE00BFXG1179.USD","BK4532","LU1506573853.SGD","IE00BN8TJ469.HKD","IE000M9KFDE8.USD","LU2129689605.HKD","LU2129689514.USD","LU2133065610.SGD","LU1551013342.USD","IE0009355771.USD","LU1280957306.USD","IE0034235303.USD","IE000MB6IJN5.SGD","LU0098860793.USD","LU2896262040.SGD","LU0289739699.SGD","LU2430703178.SGD","LU1261432733.SGD","LU0820561818.USD","LU0345770308.USD","LU0234572021.USD","LU0426417589.USD","LU2129689431.USD","LU1778281490.HKD","LU1221951046.USD","LU0320765646.SGD","LU2487616109.SGD","BK4007","BK4592","BK4534","LU1894683348.USD","LU2403377893.USD","LU0124676726.USD","LU0345769128.USD","LU1196500208.SGD","LU2112291526.USD","LU2456880835.USD","SG9999013999.USD","SGXZ57979304.SGD","SG9999002232.USD","IE00BLSP4452.SGD","LU1032466523.USD","LU1496350502.SGD","LU1061106388.HKD","IE00BGHQF631.EUR","LU2089984988.USD","LU1162221912.USD","IE0000B7K699.USD","SG9999001176.USD","LU0689626769.HKD","LU1066051811.HKD","IE00BVYPNW00.USD","LU0053666078.USD","LU2023250330.USD","BK4588","LU0985320562.USD","IE000SO60NU8.SGD","LU1066053197.SGD","LU0820561909.HKD","IE00BVYPNV92.GBP","IE00B19Z3B42.SGD","SG9999002224.SGD","LU0432979614.USD","LU2471134879.HKD","LU1732799900.SGD","LU1121112475.USD","LU2505996681.GBP","SG9999001440.SGD","LU2236285917.USD","LU1228905540.USD","IE00BBT3K403.USD","IE00B3T34201.USD","LU0689472784.USD","LU0994945656.USD","IE00BJT1NW94.SGD","LU0426412945.USD","IE00B4R5TH58.HKD","LU0234570918.USD","LU0122379950.USD","LU0640476718.USD","LU1244550577.SGD","IE00B1BXHZ80.USD","LU1066051498.USD","LU2756315318.SGD","LU1894683264.USD","JNJ","IE00B7SZLL34.SGD","IE000WAW04H5.SGD","LU1057294990.SGD","LU2430703251.USD","LU2347655156.SGD","LU1674673691.USD","IE00B3PB1722.GBP","BK4585","IE000BZT7R73.USD","LU1059921491.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169109346","title":"Imaavy® (Nipocalimab-Aahu)在关键性2/3期研究中展现持久血红蛋白应答与快速起效，针对尚无FDA批准疗法的温抗体型自身免疫性溶血性贫血","url":"https://stock-news.laohu8.com/highlight/detail?id=1169109346","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169109346?lang=zh_cn&edition=full","pubTime":"2026-06-11 14:04","pubTimestamp":1781157857,"startTime":"0","endTime":"0","summary":"Imaavy® (Nipocalimab-Aahu)在一项针对温抗体型自身免疫性溶血性贫血的关键性2/3期研究中，展现出持久的血红蛋白应答与快速的起效速度。温抗体型自身免疫性溶血性贫血是一种由自身抗体驱动的疾病，目前尚无任何疗法获得美国食品药品监督管理局的批准。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1244550221.USD","IE000WAW04H5.SGD","LU1983299246.USD","SG9999001440.SGD","LU0545562505.USD","LU2129689431.USD","IE000MB6IJN5.SGD","LU2430703095.HKD","LU2456880835.USD","LU2487616109.SGD","LU2750360997.AUD","LU0098860793.USD","LU1267930813.SGD","LU1732799900.SGD","IE00BZ1G4Q59.USD","LU1196500208.SGD","IE000SO60NU8.SGD","LU1551013425.SGD","IE00BFXG1179.USD","LU0345770993.USD","LU0820561818.USD","LU1629891620.HKD","LU0820561909.HKD","LU1032466523.USD","IE00B3T34201.USD","LU2602419157.SGD","LU1732800096.USD","SG9999002224.SGD","BK4568","BK4581","LU0689472784.USD","LU0882574055.USD","IE00BVYPNW00.USD","LU1043141396.HKD","SG9999001176.SGD","LU2112291526.USD","LU1066053197.SGD","IE00BJT1NW94.SGD","LU2756315664.SGD","IE00BBT3K403.USD","LU0210528500.USD","BK4007","LU1496350502.SGD","LU1162221912.USD","LU0345769631.USD","IE000F7OJYX1.SGD","LU1935042991.SGD","IE0009355771.USD","LU2468319806.SGD","LU0912757837.SGD","LU1674673691.USD","LU1228905540.USD","LU2213496289.HKD","LU2505996509.AUD","IE00BJJMRZ35.SGD","LU2430703251.USD","LU0058720904.USD","LU0345770308.USD","LU2471134523.USD","LU2471134796.USD","BK4532","LU2471134952.CNY","LU1244550494.USD","IE000M9KFDE8.USD","LU1066051498.USD","BK4533","IE00BGHQF631.EUR","LU2023250330.USD","BK4534","IE00BVYPNV92.GBP","LU0994945656.USD","IE00B19Z3B42.SGD","LU0053666078.USD","LU1074936037.SGD","LU1145028129.USD","LU1023059063.AUD","BK4550","LU1674673428.USD","IE00B42XCP33.USD","LU1261432733.SGD","IE00BLSP4239.USD","IE00B4R5TH58.HKD","SG9999013999.USD","JNJ","LU1894683348.USD","LU0289739699.SGD","LU0964807845.USD","LU2417539215.USD","IE00BLSP4452.SGD","LU1066051811.HKD","IE00B1BXHZ80.USD","LU0124676726.USD","LU0203345920.USD","LU1057294990.SGD","LU0070217475.USD","LU2347655156.SGD","IE0000B7K699.USD","BK4504","LU1059921491.USD","LU2236285917.USD","LU1585245621.USD","LU0426412945.USD","LU1894683264.USD","LU0795875086.SGD","IE0002270589.USD","SGXZ57979304.SGD","LU2089984988.USD","LU0943347566.SGD","LU0820562030.AUD","LU2592432038.USD","LU0210536198.USD","LU0889566641.SGD","LU1914381329.SGD","LU0426417589.USD","LU2505996681.GBP","LU2756315318.SGD","LU2129689605.HKD","IE00BKVL7J92.USD","SG9999001176.USD","LU0203347892.USD","LU1506573853.SGD","LU1066051225.USD","IE00B19Z3581.USD","LU1280957306.USD","LU0640476718.USD","LU0122379950.USD","IE00BFTCPJ56.SGD","LU1778281490.HKD","LU1221951129.SGD","LU1551013342.USD","LU2133065610.SGD","IE00BN8TJ469.HKD","LU2129689514.USD","LU0114720955.EUR","LU0320765646.SGD","IE0001KFT4U8.USD","LU0234572021.USD","LU1430594728.SGD","IE00B3PB1722.GBP","LU1043141123.HKD","LU0466842654.USD","LU1221951046.USD","BK4585","LU2430703178.SGD","LU0689626769.HKD","SG9999002232.USD","LU0985320562.USD","LU0795875169.SGD","LU1929549753.HKD","IE00B2B36J28.USD","LU1121112475.USD","LU0345769128.USD","LU1228905037.USD","LU1718418525.SGD","LU0234570918.USD","LU1061106388.HKD","IE0034235303.USD","LU0792757196.USD","LU2471134879.HKD","LU0683600562.USD","BK4588","LU1244550577.SGD","BK4592","IE000BZT7R73.USD","LU2403377893.USD","LU2750360641.GBP","LU2896262040.SGD","BK4559","IE0002141913.USD","IE00B7SZLL34.SGD","IE00BDGV0183.EUR","LU1032955483.USD","IE00BSNM7G36.USD","LU0787776722.HKD","LU0432979614.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109191646","title":"强生高管称银屑病口服药Icotyde现有约4500名处方医生 直接面向消费者营销活动预计即将启动——高盛医疗健康大会","url":"https://stock-news.laohu8.com/highlight/detail?id=1109191646","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109191646?lang=zh_cn&edition=full","pubTime":"2026-06-09 22:49","pubTimestamp":1781016562,"startTime":"0","endTime":"0","summary":"强生公司高管在高盛医疗健康大会上透露，其银屑病口服药物Icotyde目前已有约4500名医生开具处方。此外，针对该药物的直接面向消费者的营销活动预计将在近期启动。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0210528500.USD","LU0792757196.USD","LU0964807845.USD","IE0000B7K699.USD","LU1935042991.SGD","IE00BLSP4452.SGD","SG9999001176.SGD","IE00BJJMRZ35.SGD","LU1244550577.SGD","LU1914381329.SGD","LU2750360997.AUD","LU2756315664.SGD","LU1066051811.HKD","LU1043141123.HKD","LU1244550494.USD","LU1551013342.USD","IE00BVYPNW00.USD","LU1059921491.USD","LU0683600562.USD","BK4007","IE000MB6IJN5.SGD","IE00BFTCPJ56.SGD","IE0009355771.USD","SG9999002224.SGD","BK4533","BK4588","LU0124676726.USD","LU0234570918.USD","LU0689472784.USD","LU0994945656.USD","LU1066053197.SGD","LU0203347892.USD","LU0426417589.USD","LU1894683348.USD","IE0002270589.USD","LU1261432733.SGD","LU0345769128.USD","LU1221951129.SGD","LU0787776722.HKD","LU2592432038.USD","LU2347655156.SGD","IE000BZT7R73.USD","LU0234572021.USD","LU0058720904.USD","LU2896262040.SGD","LU2487616109.SGD","IE0034235303.USD","IE00BVYPNV92.GBP","LU1023059063.AUD","IE0002141913.USD","SG9999001440.SGD","LU0345770993.USD","LU0122379950.USD","LU0640476718.USD","LU2023250330.USD","LU0289739699.SGD","LU0345769631.USD","LU0426412945.USD","LU1718418525.SGD","SGXZ57979304.SGD","BK4585","SG9999002232.USD","SG9999001176.USD","BK4504","IE00B7SZLL34.SGD","JNJ","LU1674673691.USD","IE00B19Z3B42.SGD","LU2505996509.AUD","IE00BLSP4239.USD","LU0545562505.USD","LU2129689431.USD","LU1221951046.USD","LU2236285917.USD","LU1629891620.HKD","LU2756315318.SGD","LU2750360641.GBP","LU1043141396.HKD","LU1032955483.USD","BK4532","LU0320765646.SGD","LU2129689514.USD","LU0912757837.SGD","LU2430703178.SGD","LU1162221912.USD","LU1894683264.USD","LU0203345920.USD","LU1585245621.USD","LU2456880835.USD","LU2505996681.GBP","LU2430703251.USD","BK4592","LU1228905037.USD","LU2213496289.HKD","LU1280957306.USD","IE00BKVL7J92.USD","IE00B3T34201.USD","LU2403377893.USD","LU1228905540.USD","IE00BSNM7G36.USD","LU1551013425.SGD","LU0098860793.USD","LU0820561909.HKD","LU2468319806.SGD","BK4568","BK4581","LU1032466523.USD","LU2112291526.USD","LU2602419157.SGD","IE000M9KFDE8.USD","LU1074936037.SGD","LU1732800096.USD","LU1066051498.USD","LU0466842654.USD","LU1196500208.SGD","LU1066051225.USD","LU2430703095.HKD","LU1496350502.SGD","LU0820561818.USD","LU0882574055.USD","IE0001KFT4U8.USD","IE00B42XCP33.USD","LU0985320562.USD","LU0795875086.SGD","LU0889566641.SGD","LU2471134796.USD","LU1983299246.USD","IE00B3PB1722.GBP","LU0114720955.EUR","LU2471134952.CNY","LU0070217475.USD","IE00BZ1G4Q59.USD","IE00BBT3K403.USD","LU1506573853.SGD","LU0795875169.SGD","LU1145028129.USD","LU1732799900.SGD","IE00B19Z3581.USD","LU1430594728.SGD","LU1929549753.HKD","IE000F7OJYX1.SGD","IE00BGHQF631.EUR","IE00B2B36J28.USD","LU0943347566.SGD","LU1778281490.HKD","LU2089984988.USD","LU0820562030.AUD","LU0053666078.USD","LU0689626769.HKD","IE00BDGV0183.EUR","LU1267930813.SGD","LU2417539215.USD","BK4559","LU2133065610.SGD","LU1674673428.USD","LU0210536198.USD","IE00B4R5TH58.HKD","BK4534","LU1057294990.SGD","IE00B1BXHZ80.USD","LU0345770308.USD","IE00BFXG1179.USD","LU1061106388.HKD","IE00BJT1NW94.SGD","LU2471134879.HKD","LU1244550221.USD","IE000WAW04H5.SGD","BK4550","LU0432979614.USD","IE000SO60NU8.SGD","LU2129689605.HKD","LU2471134523.USD","LU1121112475.USD","IE00BN8TJ469.HKD","SG9999013999.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178922449","title":"英国MHRA授权尼泊卡单抗（商品名：Imaavy）用于治疗成人和12岁及以上青少年全身型重症肌无力","url":"https://stock-news.laohu8.com/highlight/detail?id=1178922449","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178922449?lang=zh_cn&edition=full","pubTime":"2026-06-09 20:29","pubTimestamp":1781008161,"startTime":"0","endTime":"0","summary":"英国药品和健康产品管理局（MHRA）已批准新药尼泊卡单抗（商品名：Imaavy）上市，用于治疗成人和12岁及以上青少年患者的全身型重症肌无力。该药物由强生公司研发，旨在为这一罕见自身免疫性神经系统疾病提供新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2505996681.GBP","IE00B3PB1722.GBP","IE0001KFT4U8.USD","IE000SO60NU8.SGD","LU2471134952.CNY","LU0122379950.USD","LU1718418525.SGD","LU1929549753.HKD","LU1983299246.USD","LU0058720904.USD","BK4534","LU2089984988.USD","LU1430594728.SGD","LU2430703251.USD","LU2430703095.HKD","SG9999002232.USD","LU0203347892.USD","LU1267930813.SGD","LU1032955483.USD","LU1162221912.USD","LU0912757837.SGD","LU1244550221.USD","LU0683600562.USD","LU2129689605.HKD","BK4504","IE00B42XCP33.USD","IE00BKVL7J92.USD","IE00BVYPNW00.USD","IE000WAW04H5.SGD","LU0889566641.SGD","LU2505996509.AUD","LU1496350502.SGD","LU1059921491.USD","BK4581","LU0994945656.USD","LU1551013342.USD","LU0289739699.SGD","LU2129689514.USD","IE000F7OJYX1.SGD","LU0345769128.USD","LU1023059063.AUD","LU1221951046.USD","LU1629891620.HKD","LU2213496289.HKD","BK4568","IE00BDGV0183.EUR","IE0000B7K699.USD","LU1935042991.SGD","IE00B1BXHZ80.USD","LU1032466523.USD","LU0985320562.USD","LU0320765646.SGD","BK4550","IE000BZT7R73.USD","IE00B19Z3581.USD","IE00BLSP4452.SGD","IE00B7SZLL34.SGD","LU1244550577.SGD","LU1732800096.USD","LU2430703178.SGD","LU1043141123.HKD","LU0964807845.USD","LU1551013425.SGD","BK4007","IE00BN8TJ469.HKD","LU1066051811.HKD","LU2133065610.SGD","IE00BVYPNV92.GBP","LU0787776722.HKD","IE00BZ1G4Q59.USD","IE00BJT1NW94.SGD","LU1280957306.USD","BK4585","IE00BLSP4239.USD","LU1074936037.SGD","LU2602419157.SGD","LU2487616109.SGD","LU0345770308.USD","IE000MB6IJN5.SGD","IE00BFTCPJ56.SGD","LU0943347566.SGD","LU0234572021.USD","SG9999001176.USD","LU0795875169.SGD","LU2417539215.USD","LU0345770993.USD","LU0426412945.USD","LU2236285917.USD","JNJ","LU2750360997.AUD","LU0210536198.USD","LU2468319806.SGD","LU2403377893.USD","IE00BBT3K403.USD","LU1043141396.HKD","LU1261432733.SGD","LU1674673691.USD","LU2112291526.USD","LU0795875086.SGD","LU2023250330.USD","SG9999013999.USD","LU1244550494.USD","LU0426417589.USD","LU0124676726.USD","LU1894683348.USD","SG9999002224.SGD","LU1228905037.USD","BK4532","LU1066051225.USD","LU0070217475.USD","LU0098860793.USD","BK4592","LU0345769631.USD","SG9999001440.SGD","LU0432979614.USD","LU2750360641.GBP","LU1057294990.SGD","IE00B3T34201.USD","IE0002141913.USD","LU0545562505.USD","LU1914381329.SGD","BK4533","LU2471134879.HKD","LU2347655156.SGD","LU0234570918.USD","LU1061106388.HKD","LU1894683264.USD","LU0820561909.HKD","LU1228905540.USD","LU2896262040.SGD","LU0689626769.HKD","IE000M9KFDE8.USD","LU1585245621.USD","SG9999001176.SGD","LU1778281490.HKD","IE00B4R5TH58.HKD","LU0466842654.USD","LU1506573853.SGD","LU0114720955.EUR","LU2756315318.SGD","LU1121112475.USD","LU2471134523.USD","LU2129689431.USD","LU2471134796.USD","LU0689472784.USD","LU0210528500.USD","LU0820562030.AUD","IE00BFXG1179.USD","LU1145028129.USD","IE0009355771.USD","IE00B2B36J28.USD","LU1221951129.SGD","IE0002270589.USD","LU0820561818.USD","LU1196500208.SGD","LU1732799900.SGD","LU2756315664.SGD","IE00BJJMRZ35.SGD","IE00BSNM7G36.USD","IE00B19Z3B42.SGD","IE00BGHQF631.EUR","SGXZ57979304.SGD","LU0053666078.USD","LU0640476718.USD","LU2456880835.USD","BK4588","LU1066051498.USD","LU0882574055.USD","LU0203345920.USD","LU0792757196.USD","LU1674673428.USD","IE0034235303.USD","LU2592432038.USD","BK4559","LU1066053197.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641848296","title":"强生(JNJ)将以10亿美元全现金方式收购生物技术公司Firefly 卡位下一代抗体工程","url":"https://stock-news.laohu8.com/highlight/detail?id=2641848296","media":"金吾财讯","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641848296?lang=zh_cn&edition=full","pubTime":"2026-06-08 21:04","pubTimestamp":1780923864,"startTime":"0","endTime":"0","summary":"金吾财讯 | 强生公司 宣布已达成最终协议，将以10亿美元全现金方式收购新锐生物技术公司Firefly Bio, Inc.。通过此次收购，强生将把Firefly独有的Firelink降解抗体偶联物技术平台收入囊中，旨在攻克靶向泛KRAS及其他难治性实体瘤驱动因素，全面深化其在下一代抗体工程领域的领军地位。","market":"other","thumbnail":"https://static.szfiu.com/news/20250107/MDhjNmU2MGE5ZmU5MzgyMDQ4NDM0MDU5MzkwMTYw.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/MDhjNmU2MGE5ZmU5MzgyMDQ4NDM0MDU5MzkwMTYw.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"301276","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0124676726.USD","LU0203345920.USD","LU0689472784.USD","IE000WAW04H5.SGD","LU2213496289.HKD","IE00BSNM7G36.USD","IE00BFXG1179.USD","LU2468319806.SGD","LU0820562030.AUD","IE00B3PB1722.GBP","LU0210536198.USD","LU2089984988.USD","LU2430703095.HKD","BK4007","LU0234570918.USD","LU1221951046.USD","IE0000B7K699.USD","LU0640476718.USD","LU0994945656.USD","LU1244550221.USD","LU0053666078.USD","LU1506573853.SGD","IE000M9KFDE8.USD","IE00B42XCP33.USD","LU1732799900.SGD","IE00BLSP4239.USD","LU2430703251.USD","LU0545562505.USD","LU1267930813.SGD","LU1935042991.SGD","LU1074936037.SGD","JNJ","IE00BLSP4452.SGD","LU2750360641.GBP","IE00BVYPNW00.USD","BK4592","IE000F7OJYX1.SGD","LU0943347566.SGD","LU1066051225.USD","LU0432979614.USD","IE0002141913.USD","LU1244550494.USD","LU2023250330.USD","LU1221951129.SGD","LU0203347892.USD","LU2505996681.GBP","LU2602419157.SGD","LU1718418525.SGD","LU2430703178.SGD","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123944460","title":"强生拟收购Firefly Bio以拓展其肿瘤治疗产品线 引入新型降解抗体偶联平台","url":"https://stock-news.laohu8.com/highlight/detail?id=1123944460","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123944460?lang=zh_cn&edition=full","pubTime":"2026-06-08 20:05","pubTimestamp":1780920336,"startTime":"0","endTime":"0","summary":"强生公司宣布，将收购Firefly Bio公司，旨在通过引入其创新的降解抗体偶联平台，进一步扩展其肿瘤学产品管线。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0689626769.HKD","IE00BFXG1179.USD","IE00B2B36J28.USD","LU1061106388.HKD","LU1629891620.HKD","LU0882574055.USD","LU2347655156.SGD","LU1066053197.SGD","LU1935042991.SGD","LU1894683348.USD","LU1244550494.USD","LU2471134952.CNY","LU0964807845.USD","LU1551013342.USD","LU0820561818.USD","LU2430703178.SGD","SG9999001176.USD","IE00BVYPNV92.GBP","BK4581","LU0820562030.AUD","LU2456880835.USD","BK4559","LU0912757837.SGD","LU0689472784.USD","LU0124676726.USD","BK4550","IE00BGHQF631.EUR","IE0001KFT4U8.USD","LU1066051498.USD","LU0058720904.USD","LU0683600562.USD","IE00BFTCPJ56.SGD","LU2756315318.SGD","LU0345769128.USD","IE00B7SZLL34.SGD","LU1496350502.SGD","LU2468319806.SGD","BK4533","LU2592432038.USD","IE00BLSP4452.SGD","LU1059921491.USD","LU1043141123.HKD","LU2471134523.USD","LU1551013425.SGD","LU2112291526.USD","IE00BZ1G4Q59.USD","LU1267930813.SGD","IE00BJT1NW94.SGD","LU0466842654.USD","LU2471134796.USD","LU0640476718.USD","LU2236285917.USD","LU2430703095.HKD","LU0795875086.SGD","LU1221951129.SGD","LU0820561909.HKD","LU2213496289.HKD","LU0943347566.SGD","LU2129689514.USD","LU1894683264.USD","LU0114720955.EUR","LU1023059063.AUD","LU0432979614.USD","LU1929549753.HKD","LU2487616109.SGD","LU1674673428.USD","LU0787776722.HKD","BK4588","LU0070217475.USD","IE00B19Z3B42.SGD","LU1506573853.SGD","LU0889566641.SGD","LU2756315664.SGD","LU0234572021.USD","IE0034235303.USD","BK4585","LU0545562505.USD","IE00B3T34201.USD","LU0122379950.USD","IE00B1BXHZ80.USD","LU1228905037.USD","JNJ","LU0985320562.USD","IE000F7OJYX1.SGD","LU1196500208.SGD","LU2403377893.USD","BK4592","LU1261432733.SGD","IE0000B7K699.USD","LU2896262040.SGD","LU1585245621.USD","LU0426412945.USD","LU1032466523.USD","LU1732800096.USD","BK4532","LU1674673691.USD","LU0994945656.USD","LU2129689431.USD","SGXZ57979304.SGD","IE000MB6IJN5.SGD","IE000WAW04H5.SGD","LU0320765646.SGD","LU1074936037.SGD","IE000M9KFDE8.USD","IE00BBT3K403.USD","LU2750360641.GBP","IE00BKVL7J92.USD","LU1162221912.USD","IE00B42XCP33.USD","LU0792757196.USD","LU1057294990.SGD","LU2471134879.HKD","LU0203345920.USD","LU0345770308.USD","LU1221951046.USD","IE00B19Z3581.USD","SG9999013999.USD","IE0002270589.USD","LU2505996681.GBP","SG9999001440.SGD","LU1914381329.SGD","IE0002141913.USD","LU1032955483.USD","LU2417539215.USD","IE00BSNM7G36.USD","LU2089984988.USD","LU1778281490.HKD","IE000BZT7R73.USD","LU0210528500.USD","LU0203347892.USD","BK4504","LU2430703251.USD","SG9999002224.SGD","LU0345770993.USD","LU1732799900.SGD","SG9999002232.USD","LU1066051225.USD","LU2505996509.AUD","LU0098860793.USD","IE00BVYPNW00.USD","IE00B3PB1722.GBP","LU1430594728.SGD","LU1983299246.USD","LU2602419157.SGD","LU2129689605.HKD","IE00BDGV0183.EUR","LU0053666078.USD","LU1244550221.USD","IE0009355771.USD","LU2023250330.USD","BK4568","SG9999001176.SGD","IE00BLSP4239.USD","LU0234570918.USD","LU0289739699.SGD","IE00B4R5TH58.HKD","LU1228905540.USD","LU1718418525.SGD","LU0795875169.SGD","LU1280957306.USD","BK4534","IE000SO60NU8.SGD","LU1043141396.HKD","LU2750360997.AUD","IE00BJJMRZ35.SGD","LU0210536198.USD","LU1244550577.SGD","LU1066051811.HKD","LU0426417589.USD","LU2133065610.SGD","BK4007","LU1145028129.USD","LU0345769631.USD","IE00BN8TJ469.HKD","LU1121112475.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641212565","title":"强生胜诉 此前有诉讼指控其滑石粉导致三名女性患癌","url":"https://stock-news.laohu8.com/highlight/detail?id=2641212565","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641212565?lang=zh_cn&edition=full","pubTime":"2026-06-06 08:57","pubTimestamp":1780707420,"startTime":"0","endTime":"0","summary":"近日，洛杉矶陪审团在一桩由三名女性家属提起的诉讼中支持强生公司，这些家属指控该公司的滑石粉产品导致了卵巢癌。陪审团裁定，强生公司在销售化妆品用滑石粉产品时不存在过失。 已有超过67000名原告起诉强生公司，指控其婴儿爽身粉及其他滑石粉产品导致卵巢癌。 强生公司已于2020年停止在美国销售含滑石粉的婴儿爽身粉，转而销售玉米淀粉产品。 强生公司已就大部分指控其产品导致间皮瘤的案件达成和解。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-06-06/doc-iniamnzu2195114.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0203345920.USD","IE00B2B36J28.USD","IE00B7SZLL34.SGD","LU0203347892.USD","LU2471134952.CNY","LU2129689605.HKD","LU1162221912.USD","LU2456880835.USD","SGXZ57979304.SGD","LU2896262040.SGD","LU2236285917.USD","LU1032466523.USD","BK4533","LU0124676726.USD","BK4559","IE00B4R5TH58.HKD","IE00BVYPNW00.USD","LU2756315664.SGD","LU1228905540.USD","LU0689626769.HKD","IE0009355771.USD","LU1066051225.USD","IE00BFXG1179.USD","LU0210528500.USD","LU0683600562.USD","LU2505996681.GBP","LU1145028129.USD","LU2505996509.AUD","LU0545562505.USD","IE000MB6IJN5.SGD","LU1674673428.USD","JNJ","BK4534","LU0820561818.USD","LU0234572021.USD","LU2129689514.USD","LU0882574055.USD","LU0058720904.USD","LU0943347566.SGD","BK4504","LU2602419157.SGD","LU1894683264.USD","LU1914381329.SGD","LU1066051811.HKD","SG9999002232.USD","LU0345769128.USD","IE00BDGV0183.EUR","IE00B1BXHZ80.USD","LU1043141396.HKD","IE000WAW04H5.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.jnj.com;www.investor.jnj.com;www.factsabouttalc.com","stockEarnings":[{"period":"1week","weight":0.0523},{"period":"1month","weight":0.1481},{"period":"3month","weight":0.1075},{"period":"6month","weight":0.2989},{"period":"1year","weight":0.7211},{"period":"ytd","weight":0.2913}],"compareEarnings":[{"period":"1week","weight":0.0013},{"period":"1month","weight":0.0138},{"period":"3month","weight":0.1061},{"period":"6month","weight":0.0844},{"period":"1year","weight":0.2047},{"period":"ytd","weight":0.0965}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"强生公司于1887年在新泽西州注册成立，是医疗保健领域的全球领先企业。该公司专注于研究、开发、制造、销售种类丰富的医疗保健产品，强调人类的健康和福祉。强生通过两个主要业务部门运营：创新药物和医疗技术。","yearOnYearQuotes":[{"month":1,"riseRate":0.543478,"avgChangeRate":0.00367},{"month":2,"riseRate":0.521739,"avgChangeRate":-0.001555},{"month":3,"riseRate":0.586957,"avgChangeRate":0.015928},{"month":4,"riseRate":0.617021,"avgChangeRate":0.030422},{"month":5,"riseRate":0.468085,"avgChangeRate":-0.025771},{"month":6,"riseRate":0.510638,"avgChangeRate":0.0082},{"month":7,"riseRate":0.617021,"avgChangeRate":0.014779},{"month":8,"riseRate":0.521739,"avgChangeRate":0.005146},{"month":9,"riseRate":0.5,"avgChangeRate":0.003517},{"month":10,"riseRate":0.695652,"avgChangeRate":0.021187},{"month":11,"riseRate":0.608696,"avgChangeRate":0.017686},{"month":12,"riseRate":0.652174,"avgChangeRate":0.01226}],"exchange":"NYSE","name":"强生","nameEN":"Johnson & Johnson"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"强生(JNJ)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供强生(JNJ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"强生,JNJ,强生股票,强生股票老虎,强生股票老虎国际,强生行情,强生股票行情,强生股价,强生股市,强生股票价格,强生股票交易,强生股票购买,强生股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"强生(JNJ)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供强生(JNJ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}